2026 Interim report
Filed with HKEX · Stock code 1521 · · 93 pages · English
Corporate Information ....................................... 2 Financial Highlights......................................... 3 Management Discussion and Analysis........................... 5 Corporate Governance and Other Information..................... 25 Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income................................. 43 Condensed Consolidated
Frontage Holdings Corp. on 6ix
Earlier from Frontage
- Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities
- Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development
- Frontage Europe Has Relocated Its Bioanalytical Laboratory and Further Expands Its Capabilities
- Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
- Frontage Announces Expansion of Business in Canada with New Leadership
Later from Frontage
- Notification Letter and Reply Form for Registered Shareholders
- Notification Letter and Request Form for Non-Registered Shareholders
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Frontage into a list and get an email when it puts out news.
Follow Frontage